Your session is about to expire
← Back to Search
Imaging
Micro-Ultrasound Imaging for Prostate Cancer (MUSIC-AS Trial)
N/A
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after biopsy.
Awards & highlights
MUSIC-AS Trial Summary
This trial will compare two imaging tests to measure prostate cancer progression and collect blood samples for future research.
Who is the study for?
This trial is for adult men with low-grade prostate cancer (Gleason Grade Group 1) who are being monitored closely rather than receiving immediate treatment and need a confirmatory biopsy. Participants must be able to undergo both a prostate biopsy and an MRI.Check my eligibility
What is being tested?
The study is testing if high-resolution micro-ultrasound imaging is as good as MRI in detecting significant changes in prostate cancer during active surveillance. It involves taking targeted samples using micro-ultrasound, then MRI, followed by systematic biopsies.See study design
What are the potential side effects?
While the trial itself focuses on imaging techniques that do not have side effects like drugs, undergoing biopsies can lead to discomfort, bleeding, infection risk or temporary difficulty urinating.
MUSIC-AS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediately after biopsy.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after biopsy.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Magnetic Resonance Imaging
Secondary outcome measures
Cancer upgrading during Active surveillance between imagine-guided versus systematic biopsy.
MUSIC-AS Trial Design
1Treatment groups
Experimental Treatment
Group I: Combined MRI and micro-ultrasound guided prostate biopsy.Experimental Treatment1 Intervention
In a single biopsy session, first, a microUS-guided biopsy of regions of interest (ROIs) will be performed. The MRI fusion software will then be turned on, the clinician unblinded to the MRI results, and biopsy cores from within the boundaries of the MRI-fused lesion will be sampled from ROIs. Up to two ROIs identified on microUS or MRI will be targeted with up to 3 cores per ROI. If the MRI ROIs overlap with the microUS ROIs after unblinding, then the cores taken during the microUS-guided biopsy will be counted as both microUS and MRI-guided. Finally, a standard 12-core systematic biopsy will be performed.
Find a Location
Who is running the clinical trial?
University of AlbertaLead Sponsor
889 Previous Clinical Trials
384,924 Total Patients Enrolled
9 Trials studying Prostate Cancer
5,344 Patients Enrolled for Prostate Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot have a prostate biopsy.I am unable to have a prostate MRI.I am a man with low-risk prostate cancer under active surveillance needing a confirmatory biopsy.
Research Study Groups:
This trial has the following groups:- Group 1: Combined MRI and micro-ultrasound guided prostate biopsy.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies remaining for individuals interested in participating in this clinical trial?
"As evidenced by clinicaltrials.gov, this study is currently recruiting patients. The trial was first advertised on January 1st 2023 and has been revised most recently on the 12th of January 2023."
Answered by AI
How many participants are allowed to join this experiment?
"Affirmative. The information available on clinicaltrials.gov confirms that this experiment is actively searching for participants and was published on January 1st 2023, with the last update being made on December 12th of the same year. 210 volunteers need to be recruited from a single site."
Answered by AI
Share this study with friends
Copy Link
Messenger